Shares of Immunocore Holdings PLC Sponsored ADR (IMCR) have gained 4.3% over the past four weeks to close the last trading session at $34.5, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $61.38 indicates a potential upside of 77.9%. The average comprises 13 short-term price targets ranging from a low of $34.00 to a high of $100.00, with a standard deviation of $20.87. While th ...